CA2113475A1 - Nouveaux steroides substitues en position 6 leurs procedes d'obtention et des compositions pharmaceutiques en renfermant - Google Patents
Nouveaux steroides substitues en position 6 leurs procedes d'obtention et des compositions pharmaceutiques en renfermantInfo
- Publication number
- CA2113475A1 CA2113475A1 CA002113475A CA2113475A CA2113475A1 CA 2113475 A1 CA2113475 A1 CA 2113475A1 CA 002113475 A CA002113475 A CA 002113475A CA 2113475 A CA2113475 A CA 2113475A CA 2113475 A1 CA2113475 A1 CA 2113475A1
- Authority
- CA
- Canada
- Prior art keywords
- formula
- derivative
- pregna
- dioxo
- diene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR91/09097 | 1991-07-18 | ||
| FR9109097A FR2679236B1 (fr) | 1991-07-18 | 1991-07-18 | Nouveaux sterouides substitues en position 6, leurs procedes d'obtention et des compositions pharmaceutiques en renfermant. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2113475A1 true CA2113475A1 (fr) | 1993-02-04 |
Family
ID=9415270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002113475A Abandoned CA2113475A1 (fr) | 1991-07-18 | 1992-07-17 | Nouveaux steroides substitues en position 6 leurs procedes d'obtention et des compositions pharmaceutiques en renfermant |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0595990A1 (hu) |
| JP (1) | JPH06509108A (hu) |
| KR (1) | KR100249554B1 (hu) |
| AU (2) | AU2388492A (hu) |
| BR (1) | BR9206282A (hu) |
| CA (1) | CA2113475A1 (hu) |
| FI (1) | FI940223A (hu) |
| FR (1) | FR2679236B1 (hu) |
| HU (1) | HU219456B (hu) |
| NO (1) | NO305961B1 (hu) |
| OA (1) | OA09929A (hu) |
| PL (3) | PL172677B1 (hu) |
| TN (1) | TNSN92064A1 (hu) |
| WO (1) | WO1993002095A1 (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3328729B2 (ja) | 1991-06-18 | 2002-09-30 | ラボラトアール、テラメックス、エス、ア | 抗緑内障薬剤組成物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1515284A (en) * | 1974-05-21 | 1978-06-21 | Gastaud J | Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series |
| US4512986A (en) * | 1983-07-26 | 1985-04-23 | Research Triangle Institute | Progrestationally active steroids |
| FR2552766B1 (fr) * | 1983-10-04 | 1987-06-26 | Theramex | Nouveau procede de preparation de derives de la serie du 17 a-hydroxy 19-nor progesterone |
| FR2645864B1 (fr) * | 1989-04-13 | 1991-07-12 | Theramex | Nouveaux derives alcoyles en 17/21 de la 19-nor progesterone, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant |
| FR2647452A1 (fr) * | 1989-05-24 | 1990-11-30 | Theramex | Nouveaux 19-nor steroides 6-methyles leurs procedes d'obtention, les compositions pharmaceutiques en renfermant et leur conversion en 19-nor pregnadienes 17-substitues |
-
1991
- 1991-07-18 FR FR9109097A patent/FR2679236B1/fr not_active Expired - Fee Related
-
1992
- 1992-07-17 PL PL92302050A patent/PL172677B1/pl unknown
- 1992-07-17 BR BR9206282A patent/BR9206282A/pt not_active Application Discontinuation
- 1992-07-17 HU HU9400134A patent/HU219456B/hu not_active IP Right Cessation
- 1992-07-17 PL PL92315037A patent/PL172502B1/pl unknown
- 1992-07-17 EP EP92916536A patent/EP0595990A1/fr not_active Withdrawn
- 1992-07-17 KR KR1019940700153A patent/KR100249554B1/ko not_active IP Right Cessation
- 1992-07-17 PL PL92315036A patent/PL172522B1/pl unknown
- 1992-07-17 AU AU23884/92A patent/AU2388492A/en not_active Abandoned
- 1992-07-17 WO PCT/FR1992/000697 patent/WO1993002095A1/fr not_active Application Discontinuation
- 1992-07-17 JP JP5502638A patent/JPH06509108A/ja active Pending
- 1992-07-17 CA CA002113475A patent/CA2113475A1/fr not_active Abandoned
- 1992-07-20 TN TNTNSN92064A patent/TNSN92064A1/fr unknown
-
1994
- 1994-01-14 OA OA60456A patent/OA09929A/fr unknown
- 1994-01-17 NO NO940159A patent/NO305961B1/no not_active IP Right Cessation
- 1994-01-17 FI FI940223A patent/FI940223A/fi unknown
-
1996
- 1996-08-08 AU AU61966/96A patent/AU691431B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| FR2679236B1 (fr) | 1997-01-24 |
| AU2388492A (en) | 1993-02-23 |
| HU9400134D0 (en) | 1994-05-30 |
| FI940223A0 (fi) | 1994-01-17 |
| FR2679236A1 (fr) | 1993-01-22 |
| JPH06509108A (ja) | 1994-10-13 |
| WO1993002095A1 (fr) | 1993-02-04 |
| BR9206282A (pt) | 1995-10-17 |
| AU691431B2 (en) | 1998-05-14 |
| PL172502B1 (pl) | 1997-10-31 |
| EP0595990A1 (fr) | 1994-05-11 |
| OA09929A (fr) | 1994-11-15 |
| KR100249554B1 (ko) | 2000-03-15 |
| TNSN92064A1 (fr) | 1993-06-08 |
| PL172677B1 (en) | 1997-11-28 |
| AU6196696A (en) | 1996-10-17 |
| NO305961B1 (no) | 1999-08-23 |
| NO940159L (no) | 1994-02-16 |
| HUT66021A (en) | 1994-08-29 |
| FI940223A (fi) | 1994-03-16 |
| PL172522B1 (pl) | 1997-10-31 |
| NO940159D0 (no) | 1994-01-17 |
| HU219456B (hu) | 2001-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3039996B2 (ja) | 新規なａ−ノル−ステロイド−３−カルボン酸誘導体類 | |
| CA1231939A (fr) | PROCEDE DE PREPARATION DE DERIVES DE LA SERIE DE LA 17.alpha.-HYDROXY 19-NOR-PROGESTERONE | |
| Fishman | C-3 Substituted▵ 1 (10)-Steroids1, 2 | |
| EP0443957B1 (fr) | Nouveaux produits stéroides comportant un radical spiro en position 17, leur procédé de préparation et les intermédiaires de ce procédé, leur application à titre de médicaments et les compositions pharmaceutiques les renfermant | |
| CA1140110A (fr) | Procede de preparation de nouveaux derives de l'androst-4-ene | |
| JP2752366B2 (ja) | １７α−エチニル−１７β−ヒドロキシ−１８−メチル−４，１５−エストラジエン−３−オンの製造方法、及びこの方法の中間生成物 | |
| CA2113475A1 (fr) | Nouveaux steroides substitues en position 6 leurs procedes d'obtention et des compositions pharmaceutiques en renfermant | |
| CA1051419A (fr) | Procede de preparation de nouveaux derives steroidiques | |
| EP0044575B1 (fr) | Produits intermédiaires dans la synthèse de 19-nor stéroides substitués en position 2 | |
| EP0338065B1 (fr) | Derives de la 19-nor progesterone, leur preparation et leur utilisation | |
| US5795884A (en) | 3-keto-nor-pregnenes substituted in the 6-position and treatment of menopause | |
| US3313703A (en) | 19-nor-deta4, 9, 11-pregnatriene-3, 20-dione, process and intermediates | |
| FR2645864A1 (fr) | Nouveaux derives alcoyles en 17/21 de la 19-nor progesterone, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant | |
| EP0000300A1 (fr) | Estra-1,3,5(10),6-tétraènes substitués, procédé de préparation et application dans la synthèse de stéroides marqués au tritium | |
| EP0059146B1 (fr) | Nouveaux médicaments dérivés de la 3-hydroxy dodécahydro benz (e) inden-7-one, produits dérivés de la 3-hydroxy dodécahydro benz (e) inden-7-one et leur procédé de préparation | |
| US3176030A (en) | 16alpha-lowerhydrocarbon-androsten-16beta-ol-3-one and 16-alpha-lowerhydrocarbon-androsten-16beta-ol-3-ol compounds | |
| US3096350A (en) | 6, 16alpha-dimethyl-delta1, 4, 6-pregnatriene-17alpha-ol-3, 20-dione and esters thereof | |
| JPS60252494A (ja) | エストロゲン合成阻害剤 | |
| JP2557308B2 (ja) | 新規なアンドロステンジオン誘導体 | |
| FR2647452A1 (fr) | Nouveaux 19-nor steroides 6-methyles leurs procedes d'obtention, les compositions pharmaceutiques en renfermant et leur conversion en 19-nor pregnadienes 17-substitues | |
| CH646983A5 (fr) | Derives acetyleniques chlores de l'androst-4-ene, leur preparation et medicaments les renfermant. | |
| BE667124A (hu) | ||
| JPH0684398B2 (ja) | 新規なアンドロステン誘導体及びそれを用いる６‐アルキルカルボニルオキシ‐１４α‐ヒドロキシ‐アンドロスト‐４，６‐ジエン‐３，１７‐ジオンの製造法 | |
| DE1768569A1 (de) | Neues Verfahren zur Herstellung von ungesaettigten Steroidderivaten mit modifiziertem A-Ring | |
| CH511253A (fr) | Procédé de préparation de nouveaux dérivés 2-oxa-stéroïdes insaturés |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |